Sumitomo Dainippon Pharma Co. Ltd. | Ownership
Companies that own Sumitomo Dainippon Pharma Co. Ltd.
Nomura Asset Management Co., Ltd.
12,567,296
3.16%
-19,102
0.15%
07/31/2018
Nikko Asset Management Co., Ltd.
6,787,399
1.71%
140,400
0.09%
09/03/2018
Daiwa Asset Management Co. Ltd.
5,906,699
1.48%
-242,000
0.14%
07/31/2018
The Vanguard Group, Inc.
4,328,093
1.09%
108,400
0%
07/31/2018
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
3,275,655
0.82%
16,356
0.15%
07/31/2018
BlackRock Fund Advisors
2,724,200
0.69%
-400
0%
09/06/2018
Norges Bank Investment Management
2,362,859
0.59%
-551,324
0.01%
12/31/2017
Lyxor International Asset Management SAS
2,221,996
0.56%
-260,745
0.02%
09/05/2018
Asset Management One Co., Ltd.
1,404,897
0.35%
99,097
0.02%
04/20/2018
Canada Pension Plan Investment Board
1,147,000
0.28%
-262,000
0.02%
03/31/2018
| Address |
2-6-8 Dosho-machi
Osaka Osaka 541
Japan
|
|
Employees
|
- |
| Website |
http://www.ds-pharma.co.jp |
| Updated |
07/08/2019 |
| Sumitomo Dainippon Pharma Co., Ltd. engages in manufacturing, sale, import and export of pharmaceuticals products. It operates through the Pharmaceutical Business and Other Business segments. The Pharmaceutical Business segment handles the creation of new pharmaceutical products. |
